Merck (MRK) Invested Capital (2009 - 2026)
Merck (MRK) reported Invested Capital of $48.3 billion for Q1 2026, down 2.89% year-over-year from $49.8 billion in Q1 2025, and down 12.54% on a QoQ basis from $55.3 billion in Q4 2025.
Merck (MRK) has 18 years of Invested Capital data on file, last reported at $48.3 billion in Q1 2026.
- Quarterly Invested Capital fell 2.89% year-over-year to $48.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.3 billion (down 2.89% YoY) and the FY2025 annual result came in at $55.3 billion, up 12.71% from the prior year.
- Invested Capital retreated to $48.3 billion in Q1 2026 per MRK's latest filing, from $55.3 billion in the prior quarter.
- Across five years, Invested Capital topped out at $55.3 billion in Q4 2025 and bottomed at $39.0 billion in Q4 2023.
- The 5-year median for Invested Capital is $47.7 billion (2024), against an average of $47.0 billion.
- The widest annual swing landed in 2022, when Invested Capital advanced 29.05%; it then retreated 18.74% in 2023.
- Tracing MRK's Invested Capital over 5 years: stood at $48.0 billion in 2022, then dropped by 18.74% to $39.0 billion in 2023, then climbed by 25.67% to $49.0 billion in 2024, then increased by 12.71% to $55.3 billion in 2025, then retreated by 12.54% to $48.3 billion in 2026.
- Per Business Quant, the three latest MRK Invested Capital figures stand at $48.3 billion (Q1 2026), $55.3 billion (Q4 2025), and $53.3 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 72.79 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 98.65 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -6.66 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 48.32 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 66.51 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 45.69 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 90.96 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 64.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 71.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.32 Bn |
| Dec 31, 2025 | 55.25 Bn |
| Sep 30, 2025 | 53.26 Bn |
| Jun 30, 2025 | 50.49 Bn |
| Mar 31, 2025 | 49.76 Bn |
| Dec 31, 2024 | 49.02 Bn |
| Sep 30, 2024 | 47.71 Bn |
| Jun 30, 2024 | 46.72 Bn |
| Mar 31, 2024 | 43.50 Bn |
| Dec 31, 2023 | 39.01 Bn |
| Sep 30, 2023 | 42.19 Bn |
| Jun 30, 2023 | 41.58 Bn |
| Mar 31, 2023 | 49.58 Bn |
| Dec 31, 2022 | 48.00 Bn |
| Sep 30, 2022 | 46.46 Bn |
| Jun 30, 2022 | 46.30 Bn |
| Mar 31, 2022 | 42.16 Bn |
| Dec 31, 2021 | 40.67 Bn |
| Sep 30, 2021 | 39.40 Bn |
| Jun 30, 2021 | 35.88 Bn |
| Mar 31, 2021 | 34.29 Bn |
| Dec 31, 2020 | 31.84 Bn |
| Sep 30, 2020 | 31.69 Bn |
| Jun 30, 2020 | 32.46 Bn |
| Mar 31, 2020 | 32.66 Bn |
| Dec 31, 2019 | 29.61 Bn |
| Sep 30, 2019 | 30.34 Bn |
| Jun 30, 2019 | 31.55 Bn |
| Mar 31, 2019 | 30.85 Bn |
| Dec 31, 2018 | 32.19 Bn |
| Sep 30, 2018 | 36.31 Bn |
| Jun 30, 2018 | 36.15 Bn |
| Mar 31, 2018 | 35.96 Bn |
| Dec 31, 2017 | 37.63 Bn |
| Sep 30, 2017 | 43.66 Bn |
| Jun 30, 2017 | 42.89 Bn |
| Mar 31, 2017 | 5.14 Bn |
| Dec 31, 2016 | 40.88 Bn |
| Sep 30, 2016 | 45.44 Bn |
| Jun 30, 2016 | 755.00 Mn |
| Mar 31, 2016 | 2.22 Bn |
| Dec 31, 2015 | 47.35 Bn |
| Sep 30, 2015 | 48.22 Bn |
| Jun 30, 2015 | 49.12 Bn |
| Mar 31, 2015 | 52.65 Bn |
| Dec 31, 2014 | 51.50 Bn |
| Sep 30, 2014 | 54.64 Bn |
| Jun 30, 2014 | 52.99 Bn |
| Mar 31, 2014 | 61.12 Bn |
| Dec 31, 2013 | 56.85 Bn |
| Sep 30, 2013 | 53.98 Bn |
| Jun 30, 2013 | 55.69 Bn |
| Mar 31, 2013 | 55.61 Bn |
| Dec 31, 2012 | 59.78 Bn |
| Sep 30, 2012 | 58.21 Bn |
| Jun 30, 2012 | 61.60 Bn |
| Mar 31, 2012 | 60.24 Bn |
| Dec 31, 2011 | 58.93 Bn |
| Sep 30, 2011 | 57.60 Bn |
| Jun 30, 2011 | 60.45 Bn |
| Mar 31, 2011 | 59.04 Bn |
| Dec 31, 2010 | 59.21 Bn |
| Sep 30, 2010 | 76.15 Bn |
| Jun 30, 2010 | 75.66 Bn |
| Mar 31, 2010 | 64.16 Bn |
| Dec 31, 2009 | 78.99 Bn |
| Sep 30, 2009 | 25.53 Bn |
| Jun 30, 2009 | 23.00 Bn |